Health
Oxford coronavirus vaccine is safe and triggers strong immune response, human trials show – SBS News
The vaccine prompted no serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
An experimental vaccine being developed by AstraZeneca and Oxford University against the coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The vaccine, called AZD1222, has been described by the World Health Organisation’s chief scientist as the leading candidate in a global race to halt a pandemic that has killed more than 600,000 people.
More than 150 possible vaccines are in various stage…
-
Business16 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Business18 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI
-
Business13 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General23 hours agoEngland completes sole Ashes warm-up match with flurry of runs to Ollie Pope, Joe Root